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The nomenclature of Mycobacterium ul-
cerans has become confused with the
discovery that other mycobacteria that
are not necessarily associated with Buruli
ulcer also produce the lipid toxin myco-
lactone. These mycobacteria—collectively
known as mycolactone-producing myco-
bacteria (MPM)—have been given a
variety of species names, including Myco-
bacterium shinshuense, Mycobacterium pseu-
doshottsii, Mycobacterium marinum, and Myco-
bacterium ‘‘liflandii’’. Here we highlight the
fact that all MPM share sufficient pheno-
typic and genotypic characteristics such
that they should all be formally recognised
as M. ulcerans and not separate species.
Renaming all MPM as M. ulcerans is
taxonomically correct and will resolve the
confusion that is prevalent in the field and
will assist political and financial advocacy
for Buruli ulcer.
Defining a bacterial species has become
an increasingly difficult task, particularly
when bacteria exhibit different phenotypes
but are genetically very closely related.
Genomics has shown us very clearly that
subtle genetic differences between bacteria
can result in impressive phenotypic differ-
ences. It is not surprising that the expan-
sion of bacterial genomics has led to a
reassessment of the taxonomy of many
bacterial species.
Such is the case with M. ulcerans, M.
marinum, and other closely associated
mycobacteria. M. ulcerans and M. marinum
are genetically related species that cause
quite different human skin diseases. M.
ulcerans causes Buruli ulcer, a disease
characterised by chronic and severe skin
ulcers. The bacterium produces a lipid
toxin called mycolactone, replicates slowly
(doubling time .48 h) [1], and is apig-
mented. In contrast, M. marinum causes
relatively minor granulomatous skin le-
sions, often referred to as ‘‘fish tank
granulomas’’, has a doubling time of 6–
11 h, and produces bright yellow pigments
when exposed to light. Despite their
widely different phenotypes, genome com-
parisons have shown that these species
share over 4,000 genes with 98.3%
average DNA sequence identity [2]. How-
ever, there are also some important
genetic differences between them. DNA–
DNA hybridisation (DDH) analysis con-
firmed their status as distinct species, as
inter-species relative hybridisation ratios
(RBR) were less than 40% [3,4]. The low
RBR is explained by a number of features
unique to M. ulcerans, such as the presence
of a large virulence plasmid (pMUM)
required for mycolactone production,
and multiple copies of the insertion
sequence element IS2404 that itself ac-
counts for 6% of the M. ulcerans genome
[2,5].
Mycobacteria isolated recently from
humans, fish, and frogs around the world
(including Japan, the Mediterranean Sea,
the Red Sea, Belgium, and the United
States) have been variously called M.
shinshuense, M. marinum, M. pseudoshottsii,o r
given unofficial names such as M. ‘‘liflan-
dii’’ [6–10]. Subsequent studies have used
the collective term MPM when describing
M. ulcerans and these bacteria, as they all
produce a form of mycolactone [5,11].
Phylogenetic studies of more than 50 M.
ulcerans, other MPM, and M. marinum
strains, based on multi-locus sequence
analysis (MLSA) of chromosomal and
pMUM sequences and studies of large
DNA InDel polymorphisms, indicate that
all MPM have likely evolved from a
common M. marinum progenitor [5,11,12]
and have then diverged again into two
distinct lineages, with both lineages bear-
ing strains that cause Buruli ulcer [5,13]
(Figure 1).
The new species assignations for MPM
have not considered their genomic context
and have been based on variable pheno-
typic characteristics (such as colony mor-
phology and in vitro growth rates) and
limited, monophyletic rRNA, hsp65,o r
rpoB analyses, which have shown these
mycobacteria have a few unique nucleo-
tide sequences when compared to a small
number of allele sequences in GenBank.
However, more complex and time-con-
suming DDH analyses, which, together
with 16S rRNA sequencing, are the
prescribed methods for defining a pro-
karyotic species [14], were not performed
in these studies. In the only study to utilise
DDH to investigate the relationship be-
tween recently described MPM and M.
marinum, Yip et al. (2007) showed that
MPM have an RBR of 88%–100% when
compared to M. ulcerans strains from Africa
and Australia and only 15%–60% RBR
when compared with a genetically diverse
range of nonmycolactone-producing M.
marinum strains [5] (Table 1). Furthermore,
the analysis of large sequence polymor-
phisms down to the exact nucleotide
breakpoints also showed clear clustering
of strains that have been assigned different
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ments inadequate [11].
A species is defined as ‘‘...a category
that circumscribes a (preferably) genomi-
cally coherent group of individual isolates/
strains sharing a high degree of similarity
in (many) independent features, compara-
tively tested under highly standardized
conditions’’ [15]. In practice, a prokary-
otic species is considered to be a group of
strains (including the type strain) that is
characterised by a certain degree of
phenotypic consistency, showing greater
than 97% 16S rRNA gene-sequence
identity and greater than 70% DDH
[16]. If these criteria are applied to the
MPM, all of which are ‘‘genomically
coherent’’ as revealed by MLSA and
InDel analysis, have .98% 16S rRNA
identity to M. ulcerans, .70% DDH,
possess pMUM plasmids, contain IS2404,
and make mycolactone, they can clearly
be considered as variants of the same
species, namely M. ulcerans.I ti so nt h i s
solid genetic and phenotypic basis that we
propose all MPM should be considered
strains of M. ulcerans. Furthermore, we
suggest that characteristics such as growth
rate, colony morphology, pigment pro-
duction, enzymatic activity, antibiotic
susceptibility, and pathogenicity are use-
ful traits for characterizing a particular
mycobacterium, but are too sensitive for
reliably defining a new taxon. Defining
mycobacteria that satisfy our proposed
diagnostic criteria as outlined in Table 1
as M. ulcerans will greatly simplify the
nomenclature and alleviate confusion. It
does not matter that under this revised
naming scheme some strains of M. ulcerans
will not be associated with human disease.
Indeed, many MPM, such as M. pseu-
doshottsii, have only been associated with
disease in animals other than humans;
however, they still present the same
consistent genetic signatures to assign
them as strains of M. ulcerans. Further-
more, the extent of M. ulcerans recovered
from humans to also cause disease in
other animals, including koalas, possums,
cats, and horses, is now being realised
[17,18]. These factors demonstrate how
pathogenicity or host range of a bacteri-
um is not a useful parameter for defining
a species.
Reclassifying all MPM as M. ulcerans is
more than an academic exercise. It will
also highlight both the large geographic
distribution and broad host range of this
organism. Advocacy for a neglected trop-
ical disease is not helped with confusion
about the name of the causative organism.
For example, renaming M. shinshuense to
Figure 1. Overview of the evolution and principal species-defining features of Mycobacterium ulcerans as established by multi-locus
sequence and genome deletion analysis.
doi:10.1371/journal.pntd.0000663.g001
Table 1. The Key Characteristics That Define Mycobacterium ulcerans.
Current Name Source
RBR to M.
marinum [5]
RBR
a to MU
Agy99 [5]
High Copy
IS2404
pMUM
Plasmid
Mycolactone
Produced (Type)
M. ulcerans
(Yes/No)
M. ulcerans Agy99 Human clinical isolate, Ghana 52% 100% ++ + A/B Yes
M. shinshuense 753 Human clinical isolate, Japan 29% 94% ++ + (A/B) Yes
M. pseudoshottsii L15 Striped bass (Morone saxatilis), US 41% 98% ++ + (F) Yes
M. marinum CC240299 Koi (Cyprinus carpio), Israel 39% 100% ++ + (F) Yes
M. marinum DL240490 European sea bass (Dicentrarchus
labrax), Red Sea
37% 91% ++ + (F) Yes
M. marinum DL045 European sea bass (Dicentrarchus
labrax), Mediterranean Sea
32% 94% ++ + (F) Yes
M. ‘‘liflandii’’ 128FXT African tropical clawed frog
(Xenopus tropicalis), US
33% 100% ++ + (E) Yes
M. marinum M Human clinical isolate, US 100% 52% - - - No
aRBR, relative binding ratio, derived from DNA–DNA hybridisation experiments.
doi:10.1371/journal.pntd.0000663.t001
www.plosntds.org 2 July 2010 | Volume 4 | Issue 7 | e663M. ulcerans would assist efforts to raise
awareness about Buruli ulcer in Japan.
Similarly, highlighting the fact that M.
ulcerans is found around the world, includ-
ing Europe and the US, can only help
promote research in this field and encour-
age broader community interest in Buruli
ulcer.
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